Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A24231 IFKine™ Green Donkey Anti-Goat IgG Nanomaterial‐mediated reprogramming of macrophages to inhibit refractory muscle fibrosis(A24231-26.8) 26.8 Anal Chem
A21020 HRP, Goat Anti-Rabbit IgG Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer(A21020-5) 5 Journal of Drug Delivery Science and Technology
ABL1141 Na+/K+-ATPase α1 Rabbit Polyclonal Antibody Nanoparticle-Shaped Titanium Promotes Bone Mesenchymal Stem Cell Adhesion Through Integrin α5β2(ABL1141-0) Nanoscience and Nanotechnology Letters
PRP1138 Mouse IFN-γ Protein, His tag (Animal-Free) Nanoprodrug targeting tumor-associated intracellular bacteria enhances colorectal cancer immunotherapy(PRP1138-11.5) 11.5 Applied genetics and molecular biotechnology
BMU101 Nano-selenium alleviates tetrabromobisphenol A induced PANoptosis in carp gill tissue by inhibiting TLR4/MyD88/NF-κB pathway.(BMU101-3.9) 3.9 Fish & Shellfish Immunology 
A23210 DyLight 488, Goat Anti-Mouse IgG NAP1L1 degradation by FBXW7 reduces the deubiquitination of HDGF-p62 signaling to stimulate autophagy and induce primary cisplatin chemosensitivity in …(A23210-33.9) 33.9 Front Immunol
A23630 Dylight 649, Rabbit Anti-Goat IgG NAP1L1 degradation by FBXW7 reduces the deubiquitination of HDGF-p62 signaling to stimulate autophagy and induce primary cisplatin chemosensitivity in nasopharyngeal carcinoma.(A23630-33.9) 33.9 Molecular Cancer 
BMU103 NAP1L1 degradation by FBXW7 reduces the deubiquitination of HDGF-p62 signaling to stimulate autophagy and induce primary cisplatin chemosensitivity in nasopharyngeal carcinoma.(BMU103-33.9) 33.9 Molecular Cancer 
KTA2031 EdU Cell Proliferation Image Kit (Orange Fluorescence) Nap1L4a Cooperates with Scl/Klf1 to Recruit H2A.Z in Mediating Interactions Among Cis‐Regulatory Elements and Transcription Required for Primitive …(KTA2031-14.1) 14.1 Exp Ther Med
A21010 HRP, Goat Anti-Mouse IgG Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways(A21010-3.5) 3.5 Neurochemical Research